Login
Cart
Support
Search
Search
Search
Home
eSymposia
ePanels
SciTalks
Virtual Recaps
×
Evaluation
Development of an Inhaled TLR9 Agonist for the Immunotherapy of Lung Cancer
Explore related products in the following collection:
Poster Abstracts - C717
Overview
CE Information
Comments
· · ·
Credits
Credits: None available.
Related Products
Blocking LILRB signaling impedes cancer development and targets immune checkpoints
Targeted NK cells display potent activity against glioblastoma and induce protective antitumor immunity
Modulating the tumor microenvironment to induce cross priming for cancer immunotherapy
Breast Cancer in Nigerian Women: epidemiologic features and evaluation of the utility of serum bio-markers in disease surveillance
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by
clicking here
.
Close this Window